Hotel Dieu de France
Beirut, 0000, Lebanon
NCT Number: NCT03816046
The purpose of this study is to describe two safe and reproducible techniques for the treatment of hyperhidrosis using botulinum toxin. The same patient will receive two different injection technique in each armpit and will be evaluated subjectively and objectively.
Looking for future studies?
Notify Me18 year–90 year
Male
Interventional
Phase 4
Beirut, 0000, Lebanon
The abobotulinumtoxinA (ABO) will be used in all patients. The ABO will be prepared by adding 4 cc of normal saline to a 500-unit Dysport© (Ipsen Ltd, Berks, UK) vial Preinjection patient pictures will be taken showing the technique used for each armpit.
Injection technique:
Follow up will be done at 15 days for post injection pictures with iodine starch test A total of 15 male patients will be recruited. And the injection for each armpit in a given patient is randomized.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Consecutive 15 male patients presenting to our clinic for primary localized hyperhidrosis will be included in this study
Exclusion criteria
Patient that had a liposuction in the armpit or laser for the hair
Patients with preexisting neuromuscular conditions (myasthenia gravis, Eaton Lambert syndrome) Patients using medication that could potentiate the effect of botulinum (ex: aminoglycoside antibiotics) Patients with sensitivity to botulinum toxin or human albumin
injection in hair bearing area of armpits
Time frame: 3weeks
Objective assessment will be done using the iodine starch after a 5 min jumping jack on the post injection visit.
Time frame: 3 weeks
Patient satisfaction will be determined by a questionnaire completed at 3 weeks post-treatment. Subjects will indicate how satisfied they are on a 4-point scale (1-4) as follow:
Time frame: day 0
A verbal scale from 1-10 will be addressed for every patient and every armpit
St Joseph University, Beirut, Lebanon
Other
The Quadrant vs the Six Injection Technique in Primary Focal Hyperhidrosis Using Botulinum Toxin: a Cross-over Clinical Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04924036
Amputation, Hyperhidrosis
Murray, Utah, United States
View Trial DetailsNCT01855256
Hyperhidrosis, Skin Diseases
Morlaix, France
View Trial DetailsNCT02129660
Hyperhidrosis, Skin Diseases
Encinitas, California, United States
View Trial DetailsNCT02552199
Hyperhidrosis, Skin Diseases
Carpinteria, California, United States
View Trial Details